Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

124.43
Delayed Data
As of 3:59pm ET
 -0.43 / -0.34%
Today’s Change
94.42
Today|||52-Week Range
127.64
+7.50%
Year-to-Date
Will These Three Drugs Continue Driving Celgene's Top-Line Growth?
9:49am / Zacks.com - Paid Partner Content
Infinity Pharma Focuses on Cancer Drug: Competition Looms
Mar 21 / Zacks.com - Paid Partner Content
Stock Market News for March 27, 2017
Mar 27 / Zacks.com - Paid Partner Content
Biotech Bull Making a Comeback
Mar 21 / Zacks.com - Paid Partner Content
Why Concert Pharmaceuticals Is Music to Investors' Ears
Mar 26 / TheStreet.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content
Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valean...
Mar 22 / Zacks.com - Paid Partner Content
Why Biotech Stock Gilead (GILD) Could Be a Value Trap
Mar 20 / Zacks.com - Paid Partner Content